Remote Opioid Monitoring Act of 2025
- Sponsor
- Rep. Balderson, Troy [R-OH-12]
- Committees
- Energy and Commerce Committee (primary)
- Last action
- Mar 27, 2025
Bottom line
This bill mandates a federal study to evaluate the current landscape and potential benefits of remote monitoring technologies for individuals prescribed opioids, aiming to inform future policy decisions.
What it actually does
This bill directs the Comptroller General of the United States to conduct a comprehensive study on the use of remote monitoring for individuals prescribed opioids. The study is tasked with assessing the efficacy, individual outcomes, and potential cost savings of such monitoring, its current prevalence, and providing recommendations to improve availability, access, and coverage, including through Federal health care programs.
Proponents argue
Supporters argue that understanding the role of remote monitoring in opioid management is crucial for addressing the opioid crisis, potentially improving patient outcomes, reducing misuse, and identifying cost savings. They would emphasize the need for evidence-based policy to leverage technology in healthcare to enhance safety and effectiveness.
Opponents contend
Critics might contend that while the study's intent is positive, it represents a slow approach to an urgent problem, potentially delaying concrete action. Some might also raise concerns about the scope or methodology of such a study, or question the necessity of a federal mandate for a topic that could be explored through existing research mechanisms.
The bill is exceptionally short and clear, making it very accessible for any reader to understand its purpose and provisions quickly.
Section 2
Mandate for a Study on Remote Opioid Monitoring
This section requires the Comptroller General of the United States to conduct a comprehensive study on the use of remote monitoring for individuals who are prescribed opioids. The study must assess the scientific evidence regarding its effectiveness, individual patient outcomes, and potential cost savings compared to unmonitored patients. It also needs to evaluate the current widespread use of such monitoring, including in other countries, and provide recommendations to improve its availability, access, and coverage, particularly within Federal health care programs.
Supporters argue
Supporters argue that this study is a critical first step to gather necessary data and evidence to inform effective strategies for combating the opioid crisis. They believe that remote monitoring holds promise for enhancing patient safety, preventing misuse, and potentially reducing healthcare costs, and a thorough federal study is essential to validate these benefits and guide policy.
Critics contend
Some might argue that while data is valuable, the urgency of the opioid crisis demands more immediate action than a study that will take 18 months to complete. They might suggest that existing research or pilot programs could provide sufficient information, or that this study could be a way to delay implementing more direct interventions.
Tradeoffs
The bill balances the need for evidence-based policy with the urgency of the opioid crisis. It prioritizes a comprehensive understanding of remote monitoring's effectiveness and implications before widespread implementation, potentially delaying immediate action in favor of a more informed long-term strategy.